Alternative Activation of Human Macrophages Is Rescued by Estrogen Treatment In Vitro and Impaired by Menopausal Status
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Context and Objective: During their reproductive years, women are generally protected from cardiovascular disease events by their estrogen-replete status.Our starting hypothesis was that lower estrogen levels after menopause are associated with macrophage activation profiles skewed toward proinflammatory phenotypes. Research Design and Setting:This was an in vitro and ex vivo study in human blood-derived macrophages.Subjects: We obtained blood from 12 healthy male donors for the in vitro study and from 5 premenopausal and 8 postmenopausal women for the ex vivo study. Outcome: We measured macrophage immunophenotypes in the resting state and after activation with M1-associated (lipopolysaccharide [LPS]/interferon-␥ [IFN-␥]) or M2-associated (IL-4/IL-13) stimuli and expression of estrogen receptors (ERs) and other transcription factors.Results: Unpolarized macrophages expressed both ER␣ and ER, and ER␣ but not ER levels were decreased by M1 stimuli.LPS/IFN-␥ also induced down-regulation of CD163 and CD206, markers of alternative activation, and increased cell-bound TNF-␣ and IL-10.These effects were prevented by 17-estradiol treatment through impaired nuclear factor-B liberation.In agreement with a role for 17-estradiol in attenuating the inflammatory response, M1/M2 subpopulations in monocytes and unstimulated macrophages from premenopausal and postmenopausal donors were similar.In contrast, M2 activation appeared to be blunted in macrophages from postmenopausal women, leading to an increased M1/M2 response ratio.Conclusions: Estrogen treatment prevented LPS/IFN-␥ action on human M2 macrophage markers and cytokine production, whereas menopausal estrogen loss was associated with an impaired response to alternative activation, suggesting that these mechanisms affect the cardiovascular risk profile in relation to menopausal status.(J Clin Endocrinol Metab 100: E50 -E58, 2015) M acrophages are a heterogeneous population of in- nate myeloid cells involved in health and disease (1), and their activation state can be influenced by a variety of cytokines and microbial products (2).The inflamma-tory response, particularly macrophages, is involved in the development of atherosclerosis and metabolic disease (3, 4).According to the current framework, macrophages can be polarized into classically (M1) or alternatively (M2)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 1×
“Evidence for M1/M2 activation in disease is accumulating (2, 8), yet it lacks defined subsets (9).”
BackgroundProtective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 3×
“of cytokines and microbial products (2).”
BackgroundThe M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 1×
“Evidence for M1/M2 activation in disease is accumulating (2, 8), yet it lacks defined subsets (9).”
BackgroundTranscriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210 · cited 1×
“The resulting enhancement of physiological cell functions such as migration, chemotaxis, and phagocytosis and neutralization of reactive metabolites through up-regulation of antioxidants enzymes such as sestrin-1 (36, 39) strongly indicates that glucocorticoids do not simply prevent the attenuation of anti-inflammator…”
BackgroundSex hormones and the immune response in humans
Bouman, A., Heineman, M. J., & Faas, M. M. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi008 · Cited by 1,131
Kadl, A., Meher, A. K., Sharma, P. R., Lee, M. Y., Doran, A. C., Johnstone, S. R., Elliott, M. R., Gruber, F., Han, J., Chen, W., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.215715 · Cited by 573 · cited 1×
“The M1 and M2 phenotypes were identified by expression of a variety of markers in different studies (6, 7).”
BackgroundGlucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome
Busillo, J. M., Azzam, K. M., & Cidlowski, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.275370 · Cited by 264 · cited 1×
“In contrast, LPS/IFN -induced cell-bound IL-1 production was not modulated by E2, probably because of its inability to interfere with the 2-step inflammasome/IL-1 activation pathway (34, 35).”
BackgroundCardiovascular Disease in Women
Stock, E. O., & Redberg, R. (2012) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2012.07.001 · Cited by 65
Cited by
Tedesco, S., De Majo, F., Kim, J., Trenti, A., Trevisi, L., Fadini, G. P., Bolego, C., Zandstra, P. W., Cignarella, A., & Vitiello, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00071 · Cited by 336
Self-citationEstrogen accelerates the resolution of inflammation in macrophagic cells
Villa, A., Rizzi, N., Vegeto, E., Ciana, P., & Maggi, A. (2015) · Scientific Reports · doi:10.1038/srep15224 · Cited by 272
Self-citationEstrogen Receptor Signaling in the Immune System
Chakraborty, B., Byemerwa, J., Krebs, T., Lim, F., Chang, C.-Y., & McDonnell, D. P. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac017 · Cited by 263
Estrogens in adipose tissue physiology and obesity-related dysfunction
Kuryłowicz, A. (2023) · Biomedicines · doi:10.3390/biomedicines11030690 · Cited by 178
The regulation of adipose tissue health by estrogens
Steiner, B. M., & Berry, D. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.889923 · Cited by 171
Metadata
- Authors
- Toniolo, A., Fadini, G. P., Tedesco, S., Cappellari, R., Vegeto, E., Maggi, A., Avogaro, A., Bolego, C., & Cignarella, A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-01
- Volume
- 100
- Issue
- 1
- Pages
- E50-E58
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2118116208
- Cited by
- 123
- References
- 8
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alternative Activation of Human Macrophages Is Rescued by Estrogen Treatment In Vitro and Impaired by Menopausal Status. https://app.cochat.ai/papers/10.1210/jc.2014-2751
- The paper
- Toniolo, A., Fadini, G. P., Tedesco, S., Cappellari, R., Vegeto, E., Maggi, A., Avogaro, A., Bolego, C., & Cignarella, A. (2015). Alternative Activation of Human Macrophages Is Rescued by Estrogen Treatment In Vitro and Impaired by Menopausal Status. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2014-2751
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.